Publications by authors named "Tim Lammens"

Claim this Profile
U
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia.
Patrícia Amaral, Rhona Christie, Daisy O F Gresham, Emma J M Lucas, Luyao Kevin Xu, Tim Lammens

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: A Novel L-Asparaginase with low L-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.
Hien Anh Nguyen, Ying Su, Jenny Y Zhang, Aleksandar Antanasijevic, Michael Caffrey, Tim Lammens

Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-time for LncRNA signatures in acute myeloid leukemia?
Zhiyao Ren, Barbara De Moerloose, Tim Lammens

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of THBS1 in myeloid sarcoma of acute myeloid leukemia.
Zhiyao Ren, Jolien Vanhooren, Barbara De Moerloose, Tim Lammens

Leuk Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring germline variants in genes associated with inborn errors of immunity and inherited bone marrow failure syndromes in pediatric hematological malignancies.
Jette J Bakhuizen, Freerk van Dijk, Sebastian B B Bon, Lars T van der Veken, Manon M H Huibers, Tim Lammens

Eur J Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.
Jonas De Kesel, Igor Fijalkowski, Tim Pieters, Cristina Borin, Kasper Thorhauge Christensen, Tim Lammens

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels.
Hue Vu, Evelien Peeters, Kenneth Hofkens, Katrien Vandemeulebroecke, Sara T'Sas, Tim Lammens

Biomater Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALLTogether recommendations for biobanking samples from patients with acute lymphoblastic leukaemia: a modified Delphi study.
Amélie Trinquand, James Leveson, Ana Lúcia Barbosa, Paula Gameiro, Tiina Vesterinen, Tim Lammens

Br J Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.
Jolien Vanhooren, Larissa Deneweth, Luca Pagliaro, Zhiyao Ren, Mariateresa Giaimo, Tim Lammens

Int J Mol Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target.
Laurens Van Camp, Barbara Depreter, Jilke De Wilde, Mattias Hofmans, Malaïka Van der Linden, Tim Lammens

Pediatr Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A human-like glutaminase-free asparaginase is highly efficacious in ASNS leukemia and solid cancer mouse xenograft models.
Maaike Van Trimpont, Amanda M Schalk, Kenneth Hofkens, Evelien Peeters, Sara T'Sas, Tim Lammens

Cancer Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML.
Zhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, Barbara De Moerloose, Tim Lammens

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
Stien De Coninck, Renate De Smedt, Beatrice Lintermans, Lindy Reunes, Hansen J Kosasih, Tim Lammens

Haematologica· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-Coding RNAs in Neuroblastoma: Pathogenesis, Biomarkers and Therapeutic Targets.
Niels Vercouillie, Zhiyao Ren, Eva Terras, Tim Lammens

Int J Mol Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them.
Jolien Vanhooren, Rani Dobbelaere, Charlotte Derpoorter, Larissa Deneweth, Laurens Van Camp, Tim Lammens

Hemasphere· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer.
Charlotte Derpoorter, Ruben Van Paemel, Katrien Vandemeulebroecke, Jolien Vanhooren, Bram De Wilde, Tim Lammens

Pediatr Hematol Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European standard clinical practice - Key issues for the medical care of individuals with familial leukemia.
Alisa Förster, Claudia Davenport, Nicolas Duployez, Miriam Erlacher, Alina Ferster, Tim Lammens

Eur J Med Genet· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia.
Maaike Van Trimpont, Amanda M Schalk, Yanti De Visser, Hien Anh Nguyen, Lindy Reunes, Tim Lammens

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies.
Melanie Decker, Tim Lammens, Alina Ferster, Miriam Erlacher, Ayami Yoshimi

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy in juvenile myelomonocytic leukemia: Where are we now?
Nele De Vos, Mattias Hofmans, Tim Lammens, Bram De Wilde, Nadine Van Roy

Pediatr Blood Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues.
Tom Luijts, Kerryn Elliott, Joachim Tetteh Siaw, Joris Van de Velde, Elien Beyls, Tim Lammens

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia.
Jolien Vanhooren, Laurens Van Camp, Barbara Depreter, Martijn de Jong, Anne Uyttebroeck, Tim Lammens

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy.
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M Schalk, Veerle Mondelaers, Tim Lammens

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies.
Araceli Diez-Fraile, Joke De Ceulaer, Charlotte Derpoorter, Christophe Spaas, Tom De Backer, Tim Lammens

Int J Mol Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples.
Ruben Van Paemel, Charlotte Vandeputte, Lennart Raman, Jolien Van Thorre, Leen Willems, Tim Lammens

Eur J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis